Tessenderlo Group is paying $13.30 per share for its new position, representing a 16% premium over FMC’s Tuesday closing price of $11.50. Investors responded immediately to the announcement, pushing FMC shares up 7.4% to $12.35 before the opening bell.

For FMC, the capital infusion provides the necessary liquidity to meet its $1 billion debt-reduction target. By finalizing this agreement, the company effectively concludes the broader strategic evaluation it initiated months ago to stabilize its balance sheet.